Canagliflozin, serum magnesium and cardiovascular outcomes—Analysis from the CANVAS Program

BACKGROUND: Patients with type 2 diabetes (T2D) are predisposed to derangements in serum Magnesium (Mg), which may have implications for cardiometabolic events and outcomes. In clinical trials, participants with T2D randomized to sodium‐glucose co‐transporter 2 (SGLT2) inhibitors have shown mild to...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Endocrinol Diabetes Metab
Main Authors: Wang, Katherine M., Li, JingWei, Bhalla, Vivek, Jardine, Meg J., Neal, Bruce, de Zeeuw, Dick, Fulcher, Greg, Perkovic, Vlado, Mahaffey, Kenneth W., Chang, Tara I.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2021
Teme:
Original Research Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8279612/
https://ncbi.nlm.nih.gov/pubmed/34277971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/edm2.247
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki